Transcode Therapeutics, Inc. announced that its 2026 Annual Meeting of stockholders will be held on July 2, 2026, with a record date of May 28, 2026, for voting eligibility. Shareholder proposals must be submitted by June 11, 2026.
AI Assistant
TRANSCODE THERAPEUTICS INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.